205 related articles for article (PubMed ID: 15114629)
1. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL
J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629
[TBL] [Abstract][Full Text] [Related]
2. Neuroanatomical abnormalities in behaviorally characterized APP(V717F) transgenic mice.
Dodart JC; Mathis C; Saura J; Bales KR; Paul SM; Ungerer A
Neurobiol Dis; 2000 Apr; 7(2):71-85. PubMed ID: 10783292
[TBL] [Abstract][Full Text] [Related]
3. Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein.
Kawabata S; Higgins GA; Gordon JW
Nature; 1991 Dec; 354(6353):476-8. PubMed ID: 1793460
[TBL] [Abstract][Full Text] [Related]
4. Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease.
King DL; Arendash GW; Crawford F; Sterk T; Menendez J; Mullan MJ
Behav Brain Res; 1999 Sep; 103(2):145-62. PubMed ID: 10513583
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.
Games D; Adams D; Alessandrini R; Barbour R; Berthelette P; Blackwell C; Carr T; Clemens J; Donaldson T; Gillespie F
Nature; 1995 Feb; 373(6514):523-7. PubMed ID: 7845465
[TBL] [Abstract][Full Text] [Related]
6. Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology.
Hartman RE; Wozniak DF; Nardi A; Olney JW; Sartorius L; Holtzman DM
Exp Neurol; 2001 Aug; 170(2):326-44. PubMed ID: 11476599
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.
Bales KR; Verina T; Cummins DJ; Du Y; Dodel RC; Saura J; Fishman CE; DeLong CA; Piccardo P; Petegnief V; Ghetti B; Paul SM
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15233-8. PubMed ID: 10611368
[TBL] [Abstract][Full Text] [Related]
8. Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected].
Lamb BT; Sisodia SS; Lawler AM; Slunt HH; Kitt CA; Kearns WG; Pearson PL; Price DL; Gearhart JD
Nat Genet; 1993 Sep; 5(1):22-30. PubMed ID: 8220418
[TBL] [Abstract][Full Text] [Related]
9. Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation.
Kumar-Singh S; Dewachter I; Moechars D; Lübke U; De Jonghe C; Ceuterick C; Checler F; Naidu A; Cordell B; Cras P; Van Broeckhoven C; Van Leuven F
Neurobiol Dis; 2000 Feb; 7(1):9-22. PubMed ID: 10671319
[TBL] [Abstract][Full Text] [Related]
10. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning, expression, and regulation of hippocampal amyloid precursor protein of senescence accelerated mouse (SAMP8).
Kumar VB; Vyas K; Franko M; Choudhary V; Buddhiraju C; Alvarez J; Morley JE
Biochem Cell Biol; 2001; 79(1):57-67. PubMed ID: 11235921
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease.
Holtzman DM; Bales KR; Tenkova T; Fagan AM; Parsadanian M; Sartorius LJ; Mackey B; Olney J; McKeel D; Wozniak D; Paul SM
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2892-7. PubMed ID: 10694577
[TBL] [Abstract][Full Text] [Related]
13. Formation of beta-amyloid protein deposits in brains of transgenic mice.
Quon D; Wang Y; Catalano R; Scardina JM; Murakami K; Cordell B
Nature; 1991 Jul; 352(6332):239-41. PubMed ID: 1906990
[TBL] [Abstract][Full Text] [Related]
14. Behavioral deficits in APP(V717F) transgenic mice deficient for the apolipoprotein E gene.
Dodart JC; Mathis C; Bales KR; Paul SM; Ungerer A
Neuroreport; 2000 Feb; 11(3):603-7. PubMed ID: 10718322
[TBL] [Abstract][Full Text] [Related]
15. Heat shock alters Alzheimer's beta amyloid precursor protein expression in human endothelial cells.
Ciallella JR; Rangnekar VV; McGillis JP
J Neurosci Res; 1994 Apr; 37(6):769-76. PubMed ID: 8046777
[TBL] [Abstract][Full Text] [Related]
16. [Expression of amyloid beta-protein gene in Alzheimer's disease].
Tanaka S; Nakamura S; Ueda K
Rinsho Byori; 1990 May; 38(5):489-93. PubMed ID: 2116540
[TBL] [Abstract][Full Text] [Related]
17. Intrahippocampal injections of the beta-amyloid 1-28 fragment induces behavioral deficits in rats.
Alvarez XA; Miguel-Hidalgo JJ; Fernández-Novoa L; Cacabelos R
Methods Find Exp Clin Pharmacol; 1997 Sep; 19(7):471-9. PubMed ID: 9413830
[TBL] [Abstract][Full Text] [Related]
18. Expression of APP in brains of transgenic mice containing the entire human APP gene.
Buxbaum JD; Christensen JL; Ruefli AA; Greengard P; Loring JF
Biochem Biophys Res Commun; 1993 Dec; 197(2):639-45. PubMed ID: 8267600
[TBL] [Abstract][Full Text] [Related]
19. A longitudinal study of behavioral deficits in an AβPP transgenic mouse model of Alzheimer's disease.
Havas D; Hutter-Paier B; Ubhi K; Rockenstein E; Crailsheim K; Masliah E; Windisch M
J Alzheimers Dis; 2011; 25(2):231-43. PubMed ID: 21403389
[TBL] [Abstract][Full Text] [Related]
20. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes.
Arendash GW; King DL; Gordon MN; Morgan D; Hatcher JM; Hope CE; Diamond DM
Brain Res; 2001 Feb; 891(1-2):42-53. PubMed ID: 11164808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
